PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsXiamen LP Pharmaceutical
Xiamen LP Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
ClonidineClonidine2017-11-202027-2031
Hypertension
,
Substance withdrawal syndrome
,
Diarrhea
,
Muscle spasticity
,
Glaucoma
,
Sialorrhea
,
Tourette syndrome
,
Dysmenorrhea
,
Hot flashes
,
Intractable pain
,
Nervous system alcohol-induced disorders
,
Attention deficit disorder with hyperactivity
,
Heart failure
,
Glomerulonephritis
,
Liver cirrhosis
,
Nephrotic syndrome
,
Edema
PramipexolePramipexole2021-06-112028-2029
Parkinson disease
,
Depressive disorder
,
Restless legs syndrome
TopiramateTopiramate2024-11-052027-2040
Pain
,
Epilepsy
,
Lennox gastaut syndrome
,
Infantile spasms
,
Partial epilepsies
,
Tonic-clonic epilepsy
,
Bipolar disorder
,
Obesity
Memantine donepezilMemantine, Donepezil2025-07-152025-2029
Alzheimer disease
Icosapent ethylIcosapent ethyl2025-08-06
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Aspartame
myelodysplastic syndromes
,
aplastic anemia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use